Market Share of Plasma Protease C1-inhibitor Industry
In Plasma Protease C1-inhibitor market, major players are focusing on various market strategies such as high research and development activities, partnerships, collaborations, acquisitions and mergers etc. Major players in the Plasma Protease C1-inhibitor market are CSL Behring LLC., Takeda Pharmaceutical Company Limited, Pharming Technologies B.V., KalVista Pharmaceuticals, Inc amongst others.
Plasma Protease C1-Inhibitor Market Leaders
CSL Behring LLC
Takeda Pharmaceutical Company Limited (Shire Pharmaceutical Holdings)
Pharming Technologies B.V.
KalVista Pharmaceuticals, Inc.
BioCryst Pharmaceuticals
*Disclaimer: Major Players sorted in no particular order